Lataa...
Neuroleptic malignant syndrome developing after acute overdose with olanzapine and chlorpromazine
Neuroleptic malignant syndrome (NMS) is a relatively uncommon side effect that may develop after a recent increase in the therapeutic dose of an antipsychotic medication or the addition of a new agent in therapeutic doses. CASE REPORT: We report a case of NMS developing in a 36-year-old female patie...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer-Verlag
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3550334/ https://ncbi.nlm.nih.gov/pubmed/19191213 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/BF03160978 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|